Results 21 to 30 of about 3,802,616 (346)

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Science, 2021
Description Community of antibodies against COVID-19 The severe acute respiratory syndrome coronavirus 2 spike protein is the basis of many vaccines and is a primary target of neutralizing antibodies after COVID-19 infection.
K. Hastie, Haoyang Li, Daniel H Bedinger, S. Schendel, S. Dennison, Kan Li, V. Rayaprolu, Xiaoying Yu, Colin J. Mann, M. Zandonatti, Ruben Diaz Avalos, D. Żyła, Tierra Buck, S. Hui, K. Shaffer, C. Hariharan, J. Yin, Eduardo Olmedillas, Adrian Enriquez, D. Parekh, Milite Abraha, Elizabeth Feeney, Gillian Q. Horn, Y. Aldon, Hanif Ali, Sanja Aracic, Ronald R Cobb, Ross S. Federman, Joseph M. Fernandez, J. Glanville, Robin Green, G. Grigoryan, Ana G. Lujan Hernandez, D. Ho, Kuan-Ying A. Huang, J. Ingraham, Weidong Jiang, P. Kellam, Cheolmin Kim, Minsoo Kim, Hyeong Mi Kim, Chao Kong, S. Krebs, F. Lan, Guojun Lang, Sooyoung Lee, Cheuk Lun Leung, Junli Liu, Yanan Lu, Anna J. MacCamy, A. McGuire, A. Palser, T. Rabbitts, Zahra Rikhtegaran Tehrani, Mohammad M. Sajadi, R. Sanders, A. Sato, L. Schweizer, Jimin Seo, Bingqing Shen, Jonne L. Snitselaar, L. Stamatatos, Yongcong Tan, M. Tomic, M. V. van Gils, S. Youssef, Jian Yu, Tom Z. Yuan, Qian Zhang, B. Peters, G. Tomaras, T. Germann, E. Saphire   +72 more
semanticscholar   +1 more source

The Antibody Society’s antibody validation webinar series [PDF]

mAbs, 2020
In the wake of the reproducibility crisis and numerous discussions on how commercially available antibodies as research tool contribute to it, The Antibody Society developed a series of 10 webinars to address the issues involved. The webinars were delivered by speakers with both academic and commercial backgrounds.
Andrew Bradbury, C. Glenn Begley, Alejandra Solache, Giovanna Roncador, Andrew D. Chalmers, Cecilia Williams, Cecilia Williams, Fridtjof Lund-Johansen, Travis Hardcastle, Andreas Plückthun, Michael J. Taussig, Jan L.A. Voskuil, Aldrin V. Gomes, Simon L. Goodman, James S. Trimmer, Anita Bandrowski   +15 more
openaire   +6 more sources

Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells

Frontiers in Immunology, 2016
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems.
Dubravka Drabek, Rick Janssens, Ernie de Boer, Rik Rademaker, Johannes Kloess, John Skehel, Frank Grosveld, Frank Grosveld   +7 more
doaj   +1 more source

Extreme Point Sort Transformation Combined With a Long Short-Term Memory Network Algorithm for the Raman-Based Identification of Therapeutic Monoclonal Antibodies

Frontiers in Chemistry, 2022
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling, Luxia Zheng, Mingming Xu, Gang Chen, Xiao Wang, Danzhuo Mao, Hong Shao   +6 more
doaj   +1 more source

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Science, 2020
SARS-CoV-2 antibodies persist As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg et al.
A. Wajnberg, F. Amanat, A. Firpo, D. Altman, M. Bailey, M. Mansour, Meagan McMahon, Philip Meade, D. R. Mendu, K. Muellers, D. Stadlbauer, K. Stone, Shirin Strohmeier, V. Simon, J. Aberg, D. Reich, F. Krammer, C. Cordon-Cardo   +17 more
semanticscholar   +1 more source

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

Frontiers in Oncology, 2022
DNA-encoded delivery and in vivo expression of antibody therapeutics presents an innovative alternative to conventional protein production and administration, including for cancer treatment.
Kevin Hollevoet, Kevin Hollevoet, Debby Thomas, Debby Thomas, Griet Compernolle, Griet Compernolle, Giles Vermeire, Elien De Smidt, Elien De Smidt, Stéphanie De Vleeschauwer, Trevor R. F. Smith, Paul D. Fisher, Maarten Dewilde, Maarten Dewilde, Nick Geukens, Paul Declerck, Paul Declerck   +16 more
doaj   +1 more source

Bispecific antibodies

Drug Discovery Today, 2015
Bispecific antibodies have emerged as molecules with a multitude of ...
Kontermann, Roland E., Brinkmann, Ulrich
openaire   +3 more sources

Acknowledgement to Reviewers of Antibodies in 2014

Antibodies, 2015
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Antibodies Editorial Office
doaj   +1 more source

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

bioRxiv, 2020
Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2.
Y. Weisblum, F. Schmidt, Fengwen Zhang, Justin DaSilva, D. Poston, Julio C. C. Lorenzi, F. Muecksch, Magda Rutkowska, Hans-Heinrich Hoffmann, E. Michailidis, C. Gaebler, Marianna Agudelo, A. Cho, Zijun Wang, A. Gazumyan, M. Cipolla, Larry L. Luchsinger, C. Hillyer, M. Caskey, D. Robbiani, C. Rice, M. Nussenzweig, T. Hatziioannou, P. Bieniasz   +23 more
semanticscholar   +1 more source

Acknowledgement to Reviewers of Antibodies in 2016

Antibodies, 2017
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Antibodies Editorial Office
doaj   +1 more source